Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
5.16 Down 0.02(0.39%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 17, 2014Alpha Street ResearchHunter OrrSNSS - Sunesis Pharmaceuticals Inc - Rated a Hold - Company Analysis and ASR Ranking Report9$24
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for SNSS11$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 16, 2014New Constructs, LLCN/ASNSS: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 11, 2014Pechala's ReportsFrantisek PechalaSUNESIS PHARMACEUTICALS INC (SNSS) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: DYAI , OSIR , OVAS , RPTP , SNSS -- DRUGS3$34.50
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: SUNESIS PHARMA -- SNSS1$11.50
Apr 10, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SUNESIS PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Apr 8, 2014Zacks Investment Research Inc.N/ASUNESIS PHARMA (SNSS) Zacks Company Snapshot1$11.50
Apr 5, 2014TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SUNESIS PHARMACEUTICALS INC (SNSS)5$10

View All Reports for SNSS ...